Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Thrombosis-Free Survival Data that May Inform the Way We Manage Patients with Polycythemia Vera
Thrombosis-Free Survival Data that May Inform the Way We Manage Patients with Polycythemia Vera
An Introduction to Squamous Cell Carcinoma of the Head and Neck
An Introduction to Squamous Cell Carcinoma of the Head and Neck
Bridging the Disparity Gap in Multiple Myeloma Care: Navigating Challenges, Seizing Opportunities
Bridging the Disparity Gap in Multiple Myeloma Care: Navigating Challenges, Seizing Opportunities
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups
Exploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Exploring Early Usage of a 2L ITP Treatment Option: Clinical Profile and Access Resources
Advanced Endometrial Carcinoma: A Look Into Care Considerations
Advanced Endometrial Carcinoma: A Look Into Care Considerations
Diving into New Directions of Radiopharmaceuticals
Diving into New Directions of Radiopharmaceuticals
AI in Nuclear Medicine: Improvements in the Field
AI in Nuclear Medicine: Improvements in the Field
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis
A Unique Look at the Current and Future Directions of Cancer Vaccines
A Unique Look at the Current and Future Directions of Cancer Vaccines
Patients with HER2-low mBC: Discussing the Unmet Needs and Potential Improvements
Patients with HER2-low mBC: Discussing the Unmet Needs and Potential Improvements
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens
Overcoming Barriers to Equitable Care in HNSCC
Overcoming Barriers to Equitable Care in HNSCC
Managing Immune-Related Adverse Events With Immunotherapies
Managing Immune-Related Adverse Events With Immunotherapies